[Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
Mirjana Huić, Branimir Anić, Nada Čikeš, Dubravka Bosnić, Mirna Sentić, Jasenka Markeljević, Miroslav Mayer, Leo Pažanin
Abstract
Mirjana Huić, Branimir Anić, Nada Čikeš, Dubravka Bosnić, Mirna Sentić, Jasenka Markeljević, Miroslav Mayer, Leo Pažanin
Abstract
Drug-induced myopathy and/or rhabdomyolysis have been reported with use of some statins and fibric acid derivatives. The risk of adverse effects is increased with their concomitant use. We report the case of myopathy with rhabdomyolysis during the concomitant use of cerivastatin and gemfibrozil.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Drug-induced myopathy and/or rhabdomyolysis have been reported with use of some statins and fibric acid derivatives. The risk of adverse effects is increased with their concomitant use. We report the case of myopathy with rhabdomyolysis during the concomitant use of cerivastatin and gemfibrozil.
Key concepts: Gemfibrozil, Cerivastatin, Rhabdomyolysis, Myopathy, Concomitant, Medicine, Adverse effect, Internal medicine